Law360 Speaks with Antitrust Co-Chair Saul Morgenstern on the FTC and Pay-for-Delay Settlements
Saul Morgenstern, Partner and Co-Chair of Kaye Scholer's Antitrust Practice, was quoted in Law360 on the Federal Trade Commision's (FTC) recent record-setting $1.2 billion pay-for-delay settlement with Cephalon, which gives the FTC a boost as it continues to challenge pay-for-delay settlements.
Among his comments on the FTC's settlement Morgenstern said, "Normal economic incentives being what they are, one would reasonably expect the FTC would take this as a sign that this is not a bad strategy and we will see it again. This may cause the FTC to jump into more of these cases. That only muddies the calculation for pharmaceutical companies, which already generally face claims for compensation from private plaintiffs who paid for the drugs at issue."
Morgenstern added, "It just complicates the litigation and settlement process when instead of dealing only with the people you have allegedly harmed, you're dealing with a government agency, as well, that has its own agenda and own incentives."
Also of Interest
- NLJ Names Shores as Antitrust Trailblazer September 27, 2016 • Recognitions
- Shape of Things to Come: Protecting Product Configuration and Packaging Design September 26, 2016 • Articles
- On the Road to a Safe and Secure Internet of Things: What Companies Should Do September 19, 2016 • Articles
- Arbisser Featured in The Recorder and Law360... September 7, 2016 • Media Mentions
- Consumer Products: Adapting to Innovation Fall 2016 • Reports / Newsletters
- ILS and Zinsser Analytic Shareholders Sell to Gardner Denver Medical September 2, 2016 • Client Successes
- Kaye Scholer Advises Veracen on Merger of Equals with Turner Investments August 31, 2016 • Client Successes
- Doing Deals with Competitors: Beware of Taking Minority Equity Stakes or Board Seats August 24, 2016 • Articles
- UNITED STATES: Trade Facilitation and Trade Enforcement Act of 2015 Strengthens... August 23, 2016 • Articles